Cargando…
Obinutuzumab Effectively Depletes Key B-cell Subsets in Blood and Tissue in End-stage Renal Disease Patients
The THEORY study evaluated the effects of single and multiple doses of obinutuzumab, a type 2 anti-CD20 antibody that induces antibody-dependent cell-mediated cytotoxicity and direct cell death, in combination with standard of care in patients with end-stage renal disease. METHODS. We measured B-cel...
Autores principales: | Looney, Cary M., Schroeder, Aaron, Tavares, Erica, Garg, Jay, Schindler, Thomas, Vincenti, Flavio, Redfield, Robert R., Jordan, Stanley C., Busque, Stephan, Woodle, E. Steve, Khan, Jared, Eastham, Jeffrey, Micallef, Sandrine, Austin, Cary D., Morimoto, Alyssa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851678/ https://www.ncbi.nlm.nih.gov/pubmed/36700064 http://dx.doi.org/10.1097/TXD.0000000000001436 |
Ejemplares similares
-
Efficacy and Safety of a Tofacitinib-based Immunosuppressive Regimen After Kidney Transplantation: Results From a Long-term Extension Trial
por: Busque, Stephan, et al.
Publicado: (2018) -
Nuclear Factor of Activated T Cell-regulated Cytokine Gene Expression for Adjustment of Tacrolimus in Kidney Transplant Recipients: A Randomized Controlled Pilot Trial
por: Webber, Allison B., et al.
Publicado: (2018) -
The Role of Complement Split-products as Biomarkers for Acute Antibody-mediated Rejection of Kidney Allografts
por: Abu Jawdeh, Bassam G., et al.
Publicado: (2022) -
Rituximab and Monitoring Strategies for Late Antibody-Mediated Rejection After Kidney Transplantation
por: Parajuli, Sandesh, et al.
Publicado: (2017) -
Autologous Mesenchymal Stromal Cells Prevent Transfusion-elicited Sensitization and Upregulate Transitional and Regulatory B Cells
por: Zhang, Zijian, et al.
Publicado: (2018)